Mydecine Innovations Group Announces Filing of Provisional Patent for the Treatment of PTSD with Psilocybin Psychedelics Investing
Hollister Biosciences 100% Owned Subsidiary Venom Extracts Achieves Initial $30 Million Revenue Milestone Psychedelics Investing
MindMed Partners with NYU Langone Medical Center to Launch Groundbreaking Training Program for Psychedelic Therapies and Medicines Psychedelics Investing
Nutritional High Announces an Adjustment to the Terms for Meeting of the Senior Unsecured Convertible Debentures Cannabis Investing News
Mydecine Innovations Group Announces The Official Mindleap Health Mobile App Launch in IOS and Android Stores Today Psychedelics Investing
Nutritional High's Psychedelic Sciences Prepares for Clinical Trials with Rangsit University Cannabis Investing News
Better Plant Sciences Subsidiary NeonMind Signs Psilocybin Supply Agreement for Clinical Trials Cannabis Investing News
